Ovarian Cancer
Here below, you will find a list of all the latest content published on this website on the topic of Ovarian Cancer. The content is published in chronological order. Find out more about our content categorisation.
- Pin1 protein: a druggable target in high grade serous ovarian cancer
- Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-...
- Phase I Expansion of olaparib (PARP inhibitor) and AZD5363 (AKT inhibitor) in recurrent ovarian, endometrial and triple negative breast cancer
- PALB2 Reversion Mutations in Breast, Prostate, and Ovarian Carcinomas
- Somatic loss of the wild-type BRCA1 allele is not necessarily the first event in the pathogenesis of hereditary ovarian cancer: implications for no...
- The interplay between TP53 and mevalonate pathway in ovarian cancer
- Cell context, mutation and treatment response across ovarian cancer subtypes
- Dose-finding combination study of niraparib and pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC) or recurrent p...
- Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes for Patients with Metastatic Ovarian Cancer: A Pilot Study.
- Tumor-infiltrating lymphocytes expression in stage IIIc/IV of high-grade Serous Ovarian Cancer: variation with neoadjuvant chemotherapy and prognos...
- Change of patient perceptions of chemotherapy side effects in breast and ovarian cancer patients
- NGS and Sanger screening for BRCA1/BRCA2, CHEK2 and TP53 in argentinian high-risk breast/ovarian cancer families and bioinformatic studies: initial...
- Multi-gene panels: new clinical experience in hereditary breast and ovarian cancer
- A pilot study to evaluate the feasibility, usability, and perceived satisfaction with eCO (eCediranib-Olaparib), a mobile application for side eff...
- Personalised and stratified management of non-epithelial ovarian cancer
- Personalised and stratified management of non-epithelial ovarian cancer: Discussion led by Chair
- Biological implications for clinical practice
- Front line surgery: Criteria for selection
- Medical management of recurrent disease
- Is there a role for surgical management of recurrent disease?
- Evaluation of tumour responses and olaparib efficacy in platinum-sensitive relapsed ovarian cancer (PSROC) patients (pts) with or without measurabl...
- Reproductive function in patients (pts) with malignant ovarian germ cell tumors (MOGCT) following chemotherapy (ChT)
- IMagyn050 / GOG3015 / ENGOT-ov39: A randomized, double-blind, phase III study of atezolizumab vs placebo combined with chemotherapy + bevacizumab i...
- A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 3 Trial of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cance...
- OReO/ENGOT Ov-38: A Phase IIIb trial of olaparib maintenance retreatment in patients with epithelial ovarian cancer